5.1. symptoms. many renal masses remain asymptomatic late disease stages. majority rccs detected incidentally non-invasive imaging investigating various non-specific symptoms abdominal diseases (le: 3). prospective observational cohort study, 60% patients overall, 87% patients stage 1a renal tumours 36% patients stage iii iv disease presented incidentally . classic triad flank pain, visible haematuria, palpable abdominal mass rare (6-10%) correlates aggressive histology, advanced disease, poorer outcomes [99-101] (le: 3). paraneoplastic syndromes found approximately 30% patients symptomatic rccs (le: 4). symptomatic patients present symptoms caused metastatic disease, bone pain persistent cough (le: 3). 5.1.1. physical examination physical examination limited role rcc diagnosis. however, following findings prompt radiological examinations: palpable abdominal mass;palpable cervical lymphadenopathy;non-reducing varicocele bilateral lower extremity oedema, suggests venous involvement. 5.1.2. laboratory findings commonly assessed laboratory parameters serum creatinine, glomerular filtration rate (gfr), complete cell blood count, erythrocyte sedimentation rate, liver function study, alkaline phosphatase, lactate dehydrogenase (ldh), serum corrected calcium , coagulation study, urinalysis (le: 4). central renal masses abutting invading collecting system, urinary cytology possibly endoscopic assessment considered order exclude urothelial cancer (le: 4). split renal function estimated using renal scintigraphy following situations (le: 2b): renal function compromised, indicated increased serum creatinine significantly decreased gfr;when renal function clinically important; e.g., patients solitary kidney multiple- bilateral tumours. renal scintigraphy additional diagnostic option patients risk future renal impairment due comorbid disorders.